Ventrus Biosciences Total Assets:
20.56M for Dec. 31, 2012Ventrus Biosciences Historical Total Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 20.56M |
| Sept. 30, 2012 | 23.68M |
| June 30, 2012 | 29.01M |
| March 31, 2012 | 31.39M |
| Dec. 31, 2011 | 37.05M |
| Sept. 30, 2011 | 53.39M |
| June 30, 2011 | 11.52M |
| March 31, 2011 | 14.14M |
| Dec. 31, 2010 | 14.62M |
| Sept. 30, 2010 | 0.5793M |
| June 30, 2010 | 1.156M |
| March 31, 2010 | 1.425M |
| Dec. 31, 2009 | 0.1663M |
About Total Assets
The sum of all current and long-term assets held by a company. An asset is any item with economic value that is held by a company.
Learn More
VTUS Total Assets Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 65.19B |
| Tetraphase Pharmaceuticals | 14.07M |
| Zoetis | 6.262B |
VTUS Total Assets Rankings
| Overall |
39th percentile 4585 of 7593 |
| Sector |
27th percentile 471 of 650 in Healthcare |
| Industry |
42nd percentile 30 of 52 in Drug Manufacturers - Major |
VTUS Total Assets Range, Past 5 Years
| Minimum | 0.1663M | Dec 2009 |
| Maximum | 53.39M | Sep 2011 |
| Average | 18.36M |
